Prosperity Mental Health, Shelli Craig PMHNP-APRN
2525 Kell East Boulevard, 302, Wichita Falls
4.5(8 Google reviews)
United States
2 listed treatment centers serving Wichita Falls and the surrounding area.
2525 Kell East Boulevard, 302, Wichita Falls
4.5(8 Google reviews)
The cost of SPRAVATO® treatment in Wichita Falls depends on your insurance benefits, the treatment setting, and how services are billed. The medication and the supervised visit, including required monitoring, may generate separate charges. Ask for an estimate that accounts for both—not just the nasal spray.
Prior authorization is common. Your insurer may require records of earlier antidepressant trials, including which medications you tried and how you responded. Ask the treatment center which records it needs, who submits the authorization request, and whether approval is required before your first appointment. Authorization does not necessarily mean you will have no out-of-pocket costs.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Texas Medicaid coverage also depends on the plan and applicable requirements. The two Wichita Falls listings currently indicate that they do not accept Medicare or Medicaid; verify this directly before scheduling. General program coverage does not establish that a particular center can bill your benefits.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Eligibility rules apply, and assistance may not cover every visit-related charge.
Before starting, ask the center and insurer:
SPRAVATO® treatment requires repeat trips to a REMS-certified healthcare setting. You self-administer the nasal spray there under direct observation; it is never dispensed for home use. This directory lists two Wichita Falls locations offering Spravato, but their REMS certification is not confirmed in the listing data. Verify current certification and appointment availability directly before making plans.
A typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may then be weekly or every two weeks. Your prescriber determines the schedule for your situation, so avoid assuming that visits will decrease on a fixed date.
Monitoring lasts at least two hours after each dose. Allow additional time for check-in, preparation, and the clinician's assessment of whether you are ready to leave. When arranging time off work or caregiving coverage, plan for the entire appointment and transportation—not only the monitoring period.
You need someone else to take you home. Do not drive or operate machinery until the next day after a restful sleep. Arrange rides in advance, consider a backup driver, and ask the center about its pickup and discharge requirements. Coordinate work duties accordingly, particularly if your job involves driving or machinery.
If no Wichita Falls center is listed when you search, or local options are unavailable, you can expand your search to listed centers in Fort Worth or Dallas. These are search options, not confirmed referrals or necessarily convenient alternatives. Confirm certification, intake availability, insurance arrangements, and a workable round-trip transportation plan before committing.
This directory lists two Wichita Falls locations offering Spravato, but the listing data do not confirm their REMS certification. Contact a location and ask whether it is currently certified to provide treatment, accepts new patients, and offers an eligibility assessment. If local appointments are unavailable, listings in Fort Worth or Dallas may help you broaden your search; confirm the same details before arranging travel.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and medical risks to decide whether it is appropriate; a diagnosis alone does not guarantee eligibility.
Coverage depends on your plan, the treatment setting, and authorization requirements. Insurers commonly request documentation of previous antidepressant trials. Ask about both medication and monitoring charges. Medicare and Texas Medicaid may cover treatment in some circumstances, but both Wichita Falls listings currently indicate that they do not accept those programs. Confirm acceptance, network status, and your expected share of costs directly with the center and insurer.
You administer the nasal spray yourself under direct observation at a REMS-certified setting. Staff monitor you for at least two hours after the dose, including checks for sedation, dissociation, breathing problems, and blood pressure increases. Leaving depends on the healthcare provider's assessment, so allow extra time. Someone else must take you home, and you cannot drive until the next day after a restful sleep.
Important risks include sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your medical history, medications, and any substance-use concerns with the prescriber, and tell staff promptly if you feel unwell during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when that is clinically needed. Do not wait for a treatment-center appointment during a crisis. Call or text 988 for crisis support, or call 911 in an emergency. A clinician can discuss longer-term treatment after your immediate safety needs are addressed.
Approved uses, nearby treatment centers, and medically sourced patient guides.